Company Page
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company pioneering the application of artificial intelligence and machine learning to gene therapy. The company's proprietary CapsidMap platform uses AI and high-throughput in vivo experimentation to rapidly discover and systematically optimize Adeno-Associated Virus (AAV) capsid vectors that significantly outperform current approaches for in vivo gene delivery. Dyno engineers synthetic AAV capsids with improved tissue targeting, immune evasion, and manufacturability properties, expanding the range of diseases treatable with gene therapies. The company has launched multiple breakthrough capsid vectors for brain, eye, and muscle delivery, partnering with leading gene therapy developers including Novartis, Sarepta, Roche, Spark Therapeutics, and Astellas to advance next-generation treatments.
Company Founded in 2018
Healthtech & Biotech